These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31324409)

  • 1. Thrombolysis Following Heparin Reversal With Protamine Sulfate in Acute Ischemic Stroke: Case Series and Literature Review.
    Ranasinghe T; Mays T; Quedado J; Adcock A
    J Stroke Cerebrovasc Dis; 2019 Oct; 28(10):104283. PubMed ID: 31324409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombolysis After Protamine Reversal of Heparin for Acute Ischemic Stroke After Cardiac Catheterization: Case Report and Literature Review.
    Warner DS; Schwartz BG; Babygirija R; Rovin RA; Kassam AB; Biddick L; Sajjad R; Chohan A; Panichpisal K
    Neurologist; 2018 Nov; 23(6):194-196. PubMed ID: 30379743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteplase for Acute Ischemic Stroke after Heparin Reversal with Protamine: A Case Report and Review.
    Fontaine GV; Smith SM
    Pharmacotherapy; 2017 Oct; 37(10):e103-e106. PubMed ID: 28741720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of Intravenous Thrombolysis among Stroke Patients Taking New Oral Anticoagulants--Case Series and Systematic Review of Reported Cases.
    Shahjouei S; Tsivgoulis G; Bavarsad Shahripour R; Jones GM; Alexandrov AV; Zand R
    J Stroke Cerebrovasc Dis; 2015 Dec; 24(12):2685-93. PubMed ID: 26542821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-Dose Tissue Plasminogen Activator in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
    Cheng JW; Zhang XJ; Cheng LS; Li GY; Zhang LJ; Ji KX; Zhao Q; Bai Y
    J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):381-390. PubMed ID: 29111341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous Thrombolysis After Idarucizumab Application in Acute Stroke Patients-A Potentially Increased Sensitivity of Thrombi to Lysis?
    Pretnar Oblak J; Sabovic M; Frol S
    J Stroke Cerebrovasc Dis; 2019 Mar; 28(3):768-773. PubMed ID: 30527792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clotting factors to treat thrombolysis-related symptomatic intracranial hemorrhage in acute ischemic stroke.
    Alderazi YJ; Barot NV; Peng H; Vahidy FS; Navalkele DD; Sangha N; Misra V; Savitz SI
    J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):e207-14. PubMed ID: 24321775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous Thrombolysis in Patients with Acute Ischemic Stroke after a Reversal of Dabigatran Anticoagulation with Idarucizumab: A Real-World Clinical Experience.
    Šaňák D; Jakubíček S; Černík D; Herzig R; Kunáš Z; Mikulík R; Ostrý S; Reif M; Rohan V; Tomek A; Veverka T
    J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):2479-2483. PubMed ID: 29807757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of Intravenous Thrombolysis for Acute Ischemic Stroke in Patients Taking Warfarin with Subtherapeutic INR.
    Mowla A; Memon A; Razavi SM; Lail NS; Vaughn CB; Mohammadi P; Sawyer RN; Shirani P
    J Stroke Cerebrovasc Dis; 2021 May; 30(5):105678. PubMed ID: 33640783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of Endovascular Intervention for Stroke on Therapeutic Anticoagulation: Multicenter Cohort Study and Meta-Analysis.
    Kurowski D; Jonczak K; Shah Q; Yaghi S; Marshall RS; Ahmad H; McKinney J; Torres J; Ishida K; Cucchiara B
    J Stroke Cerebrovasc Dis; 2017 May; 26(5):1104-1109. PubMed ID: 28110890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal Dysfunction Associated with Symptomatic Intracranial Hemorrhage after Intravenous Thrombolysis.
    Zhu J; Shen X; Han C; Mei C; Zhou Y; Wang H; Kong Y; Jiang Y; Fang Q; Cai X
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104363. PubMed ID: 31501038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous Thrombolysis for Acute Ischemic Stroke in Patients with Thrombocytopenia.
    Mowla A; Kamal H; Lail NS; Vaughn C; Shirani P; Mehla S; Rajabzadeh-Oghaz H; Deline C; Ching M; Crumlish A; Sawyer RN
    J Stroke Cerebrovasc Dis; 2017 Jul; 26(7):1414-1418. PubMed ID: 28438515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous Tissue Plasminogen Activator in Stroke Mimics.
    Ali-Ahmed F; Federspiel JJ; Liang L; Xu H; Sevilis T; Hernandez AF; Kosinski AS; Prvu Bettger J; Smith EE; Bhatt DL; Schwamm LH; Fonarow GC; Peterson ED; Xian Y
    Circ Cardiovasc Qual Outcomes; 2019 Aug; 12(8):e005609. PubMed ID: 31412730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinogen concentrate replacement in ischemic stroke patients after recombinant tissue plasminogen activator treatment.
    Vandelli L; Marietta M; Trenti T; Varani M; Bigliardi G; Rosafio F; Dell'acqua ML; Picchetto L; Nichelli P; Zini A
    Adv Clin Exp Med; 2019 Feb; 28(2):219-222. PubMed ID: 30507073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid-Lowering Pretreatment and Outcome Following Intravenous Thrombolysis for Acute Ischaemic Stroke: A Post Hoc Analysis of the Enhanced Control of Hypertension and Thrombolysis Stroke Study Trial.
    Minhas JS; Wang X; Arima H; Bath PM; Billot L; Broderick JP; Donnan GA; Kim JS; Lavados PM; Lee TH; Martins SCO; Olavarría VV; Pandian JD; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Thang NH; Wang JG; Woodward M; Chalmers J; Anderson CS; Robinson TG;
    Cerebrovasc Dis; 2018; 45(5-6):213-220. PubMed ID: 29705803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions.
    Seet RC; Rabinstein AA
    Cerebrovasc Dis; 2012; 34(2):106-14. PubMed ID: 22868870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous tPA for Acute Ischemic Stroke in Patients with COVID-19.
    Carneiro T; Dashkoff J; Leung LY; Nobleza COS; Marulanda-Londono E; Hathidara M; Koch S; Sur N; Boske A; Voetsch B; Aboul Nour H; Miller DJ; Daneshmand A; Shulman J; Curiale G; Greer DM; Romero JR; Anand P; Cervantes-Arslanian AM
    J Stroke Cerebrovasc Dis; 2020 Nov; 29(11):105201. PubMed ID: 33066885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals.
    Schwamm LH; Ali SF; Reeves MJ; Smith EE; Saver JL; Messe S; Bhatt DL; Grau-Sepulveda MV; Peterson ED; Fonarow GC
    Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):543-9. PubMed ID: 24046398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute Stroke Despite Dabigatran Anticoagulation Treated with Idarucizumab and Intravenous Tissue Plasminogen Activator.
    Bissig D; Manjunath R; Traylor BR; Richman DP; Ng KL
    J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):e102-e104. PubMed ID: 28416406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration of tissue plasminogen activator without coagulation results in a Chinese population.
    Qin X; Zhao S; Yin L; Dou H; Chen J; Wang Y; Li M; Chen R; Fu J; Liu W; Liu X; Yang G; Wang R; Jia X; Bu S; Ma D; Wang B; Li S
    Neurol Sci; 2018 Mar; 39(3):481-487. PubMed ID: 29299775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.